SCHEMBL472594

SCHEMBL472594

C=C(C)C(=O)OCCc1ccc(OP(=O)(O)Oc2ccc(CCOC(=O)C(=C)C)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
APEX1 P27695 1/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
THRB P10828 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
CYP2C19 P33261 1/20 0.39
TSHR P16473 3/20 0.37
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
ALDH1A1 P00352 2/20 0.34
ACACB O00763 1/20 0.34
ACACA Q13085 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL64962 0.91 POLB (0.44) POLBAPEX1HTTTDP1THRB
SCHEMBL6814509 0.87 POLB (0.43) POLBAPEX1HTTTDP1THRB
SCHEMBL11921516 0.84 THRB (0.55) POLBAPEX1HTTTDP1THRB
SCHEMBL22566492 0.83 THRB (0.53) POLBAPEX1HTTTDP1THRB
SCHEMBL5077422 0.82 THRB (0.44) POLBAPEX1HTTTDP1THRB
SCHEMBL17036777 0.82 POLB (0.58) POLBAPEX1HTTTDP1THRB
SCHEMBL148322 0.82 SMN1; SMN2 (0.56) POLBAPEX1HTTTDP1THRB
SCHEMBL345074 0.81 POLB (0.42) POLBAPEX1HTTTDP1THRB
SCHEMBL10457799 0.80 THRB (0.50) POLBAPEX1HTTTDP1THRB
SCHEMBL17036971 0.79 POLB (0.63) POLBAPEX1HTTTDP1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2716276-B1 Kit and method for indirect chair-side production of composite inlays VOCO GMBH (DE) 2019-04-24 EP claimed
EP-2628476-B1 FILLER CONTAINING COMPOSITION AND PROCESS FOR PRODUCTION AND USE THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2018-03-28 EP claimed
US-9833387-B2 Kit and method for indirect chairside production of composite inlays VOCO GMBH (DE) 2017-12-05 US claimed
EP-2374444-B1 Dental covering material VOCO GMBH (DE) 2017-03-01 EP claimed
US-20140138864-A1 KIT AND METHOD FOR INDIRECT CHAIRSIDE PRODUCTION OF COMPOSITE INLAYS VOCO GMBH (DE) 2014-05-22 US claimed
EP-2628476-A1 Filler containing Composition and Process for Production and Use thereof 3M Innovative Properties Company (US) 2013-08-21 EP claimed
US-6512068-B1 Substantially transparent adhesive composition for hard tissue, and a method for producing it; the adhesive composition exhibits good adhesiveness to hard tissue, especially to both enamel and dentin, and has the advantage of KURARAY CO., LTD. (JP) 2003-01-28 US claimed
US-20240189195-A1 DENTAL POLYMERIZABLE COMPOSITION GC CORPORATION (JP) 2024-06-13 US disclosed
US-11998417-B2 Process for producing a surface-modified dental article SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2024-06-04 US disclosed
EP-4316452-A1 POLYMERIZABLE DENTAL COMPOSITION GC Corporation (JP) 2024-02-07 EP disclosed
US-20230270630-A1 COMPOSITION FOR DENTAL ATTACHMENT KURARAY NORITAKE DENTAL INC. (JP) 2023-08-31 US disclosed
EP-4035649-B1 DENTAL ADHESIVE COMPOSITION 3M INNOVATIVE PROPERTIES COMPANY (US) 2023-07-26 EP disclosed
US-20230225829-A1 PROCESS FOR PRODUCING A SURFACE-MODIFIED DENTAL ARTICLE SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2023-07-20 US disclosed
US-20030064102-A1 Antimicrobial Composition NAKATSUKA KAZUMITSU (JP) 2003-04-03 US disclosed
EP-1287805-A1 Dental adhesive composition GC Corporation (JP) 2003-03-05 EP disclosed
EP-1285947-A1 ANTIMICROBIAL COMPOSITION KURARAY CO., LTD. (JP) 2003-02-26 EP disclosed
US-6512068-B1 Substantially transparent adhesive composition for hard tissue, and a method for producing it; the adhesive composition exhibits good adhesiveness to hard tissue, especially to both enamel and dentin, and has the advantage of KURARAY CO., LTD. (JP) 2003-01-28 US disclosed
EP-1057468-A1 Adhesive composition and method for producing it KURARAY CO., LTD. (JP) 2000-12-06 EP disclosed
US-4918136-A CURABLE MIXTURE OF VINYL MONOMER WITH ACIDIC GROUP, FILLER, POLYMERIZATION PROMOTER, ASCORBIC ACID; DENTISTRY TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1990-04-17 US disclosed
EP-0335645-A2 Adhesive composition TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1989-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270630-A1 COMPOSITION FOR DENTAL ATTACHMENT ITGA1, ITGA2, PPA1 POLB 2433/4885APEX1 194/4885HTT 2516/4885
US-20030064102-A1 Antimicrobial Composition AAAS, H1-0, H1-10 POLB 149/4885APEX1 890/4885HTT 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.